Teva leaders to present at pivotal health conference

Teva Pharmaceutical Industries Ltd. announced they will participate in the 7th Annual Evercore ISI HealthCONx Conference. This event is scheduled for December 5, 2024, where Richard Francis, President and CEO, along with Eric Hughes, Executive Vice President of Global R&D and Chief Medical Officer, will present. The conference will take place in a virtual format, with an opportunity for attendees to access a live webcast via Teva’s Investor Relations website. Following the presentation, an archived version will be available within 24 hours. Teva emphasizes the importance of this conference in discussing its strategies for growth and addressing future challenges.